SAN DIEGO, June 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) recently participated in the European Society of Human Genetics (ESHG) conference held in Milan, Italy, from May 24-27, ...
SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 2 of Bionano Symposium 2026, which focused on New Frontiers in Oncology and ...
SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics ...
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Institut Necker Enfants Malades (INEM) ...
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on ...
DUBLIN--(BUSINESS WIRE)--The "Optical Genome Mapping Market Size, Share & Trends Analysis Report, By Product (Instruments, Software), By Application (Structural Variant Detection, Genome Assembly), By ...
Neurodevelopmental disorders (NDDs) encompass conditions linked to abnormal brain development. Those with intellectual disability (ID), marked by notable limitations in intellectual functioning and ...
This study includes concurrent karyotyping, FISH, OGM, and NGS analyses on 45 PCN patients from The Johns Hopkins Hospital and The University of Texas MD Anderson Cancer Center from January 2022 to ...
April 14, 2025 – Genome Research (https://genome.org) publishes a second special issue highlighting advances in long-read sequencing applications in biology and medicine. In this second Special Issue, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results